ILC2 Diversity, Location, and Function in Pulmonary Disease

Area of Science:

• Immunology
• Pulmonology
• Cell Biology

Background:

• Type-2 inflammation, characterized by IL-4, IL-5, and IL-13, underlies key lung responses like mucus production and immune cell recruitment.
• Group 2 innate lymphoid cells (ILC2) are pivotal early sources of these type-2 cytokines, significantly influencing immune responses in the lung.
• ILC2 activity is linked to the 'weep-and-sweep' responses in mucosal tissues following epithelial damage.

Purpose of the Study:

• To review the multifaceted role of ILC2 in lung immunity and disease.
• To explore the origins of ILC2 within the context of the gut-lung axis.
• To examine the heterogeneity of ILC2 populations and their impact on pulmonary pathologies.

Main Methods:

• This is a review article, synthesizing existing research on ILC2 function in the lung.
• The review focuses on analyzing data related to ILC2 origins, heterogeneity, activation, migration, and intercellular communication.
• Literature search and critical analysis of studies investigating ILC2 in pulmonary contexts.

Main Results:

• ILC2 are critical regulators of type-2 inflammation in the lung, originating from the gut-lung axis.
• Distinct circulating and tissue-resident ILC2 populations exhibit unique characteristics and functions.
• ILC2 behavior, including activation, migration, and environmental interactions, significantly influences pulmonary disease progression.

Conclusions:

• ILC2 are essential immune cells in the lung, impacting the development and severity of various pulmonary diseases.
• Understanding ILC2 heterogeneity and their regulatory mechanisms is key to developing targeted therapies.
• Further research into the gut-lung axis and ILC2 communication networks will illuminate their broader role in respiratory health.